Audio By Carbonatix
US President Donald Trump's administration has secured almost all the world's upcoming supply of the drug remdesivir.
The drug, produced by the firm Gilead Sciences, is the first approved by authorities in the US to be used to treat Covid-19.
It has been shown to help people recover faster from the disease.
A statement from the Department of Health and Human services says Trump struck an "amazing" deal with Gilead for 500,000 doses which amounts to 100% of Gilead's production in July, 90% of it in August and 90% in September.
A treatment course of remdesivir is, on average, 6.25 vials.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
Ghana to seek review of Canada’s visa decision on Thomas Partey
2 hours -
KGL Foundation renovates Accra Psychiatric Hospital OPD
2 hours -
Zoomlion, NADMO deploy officers across Greater Accra to sustain anti-flood campaign
3 hours -
AG challenges Appiah-Kubi’s bid to withdraw from Wontumi case
3 hours -
The studio and one-bedroom advantage: Why smaller units are outperforming villas in Accra in 2026
3 hours -
How to buy off-plan in Accra without losing your money: A diaspora due diligence guide for 2026
3 hours -
Immigration law that may have kept Partey out of Canada, as England clash looms
4 hours -
NPP Sweden Chair declares bid for national first vice chairman position
4 hours -
NRSA warns motorists and pedestrians of increased road hazards amid heavy rainfall
4 hours -
One dead and at least 10 others wounded in Texas shooting
4 hours